Status: Recruiting
Pilot CAR-T Cells Therapy for Children/Young Adults With CD19+ R/R Leukemia/Lymphoma
The purpose of this study is to estimate the safety and the efficacy of CAR- T cells immunotherapy for children/young adults with relapsed or refractory acute lymphoblastic leukemia/lymphoma.
Participants needed: 10
Trial details
Phase: Phase 1Age: 1-30Biological sex: AllType: InterventionalSponsor: Belarusian Research Center for Pediatric Oncology, Hematology and ImmunologyUpdated: Aug 28, 2024Locations: 1
Eligibility criteria
CD19+ relapsed or refractory lymphoblastic leukemia/lymphoma; [+3]
primary immunodeficiencies or genetic syndromes; [+10]